HemaMetrics beats off Transonic patent suit
This article was originally published in Clinica
Executive Summary
A US court has ruled that HemaMetrics can continue marketing its Delta H dialysis access products, despite a patent challenge from Transonic. The litigation began in November 2000, when Ithaca, New York-based Transonic obtained a preliminary injunction blocking HemaMetrics from selling Delta H products in the US.